✦ LIBER ✦

Biochemical biomarkers as endpoints in clinical trials: Applications in Phase 1, 2 and 3 studies

✍ Scribed by Eric Siemers

Book ID: 118465340
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 36 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.05.292

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trials: linaclotide

Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints

✍ Quigley, E. M. M.; Tack, J.; Chey, W. D.; Rao, S. S.; Fortea, J.; Falques, M.; D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

A Phase 1/2 Clinical Trial of Enzyme Rep

A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety Studies

✍ Christine M. Eng; Maryam Banikazemi; Ronald E. Gordon; Martin Goldman; Robert Ph 📂 Article 📅 2001 🏛 American Society of Human Genetics 🌐 English ⚖ 1000 KB

P.1.f.001 Cognitive testing in early-pha

P.1.f.001 Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study

✍ A. Collie; A. Darekar; P. Maruff; P. Snyder; J.P. Huggins 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

41 POSTER Clinical and biomarker respons

41 POSTER Clinical and biomarker responses in a phase I study of BAY 57 9352 – a VEGFR-2 inhibitor – administered as continuous dosing in patients with advanced solid tumors

✍ D. Strumberg; O. Christensen; R. Strecker; M.E. Scheulen; A. Frost; P. Rajagopal 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

CLINICO-BIOCHEMICAL STUDIES ON GLUTAMIC

CLINICO-BIOCHEMICAL STUDIES ON GLUTAMIC ACID PART 1. ITS RECOVERY EFFECT ON THE INSULIN-SHOCK COMA AND ITS APPLICATION IN CLINICAL PRACTICE AS A NEW THERAPEUTIC METHOD

✍ Tanaka, Zenryu; Sakurada, Takashi 📂 Article 📅 1958 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Phase II study of cytarabine in men with

Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers

✍ Neesha C. Dhani; Urban Emmenegger; Laurie Adams; Jan Jongstra; Ian F. Tannock; S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB